Clin2
NCT07152613Possibly a fitNot yet recruiting

Steroids for Pneumocystis pneumonia in ICU adults without HIV

Pneumocystis Jiroveci Pneumonia

Part of Infections, Lungs & breathing clinical trials.

This trial tests whether adding corticosteroids helps non-HIV immunocompromised adults with severe Pneumocystis pneumonia in the ICU. If you meet the criteria, you may be randomly assigned to receive either steroids plus standard care or standard care alone.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
240 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old and in the intensive care unit (ICU).
  • You have severe pneumonia diagnosed by a doctor, either needing a breathing tube or having septic shock, or at least three other serious symptoms like fast breathing, low oxygen, confusion, or low blood pressure.
  • You have a positive test (PCR or genetic sequencing) for Pneumocystis jirovecii in your lung fluid, sputum, or throat swab.
  • You have not already been treated for this pneumonia for more than seven days before coming to the ICU.
  • You have not received steroids for this pneumonia before entering the ICU, and you are not already taking high doses of steroids for another condition.
  • You are not HIV positive, pregnant, or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07328984Not yet recruiting· Phase 4
Steroid Duration for Severe Pneumocystis Pneumonia

This trial is testing whether a shorter or longer course of steroids works better for people recovering from severe Pneumocystis pneumonia (a lung infection). If you are 18 or older and have been on steroids for about 10 days but no longer need extra oxygen, you may be able to join.

Montreal, Quebec
NCT07357935Not yet recruiting· Phase 1/Phase 2
Steroid treatment for severe pneumonia in the ICU

This trial tests if giving steroids early, based on your immune system, can help treat severe pneumonia that needs ICU care. It aims to reduce inflammation and improve recovery.

NCT07152587Not yet recruiting· Phase 2/Phase 3
Testing targeted anti-inflammatory drugs for severe pneumonia in the ICU

This trial tests if anti-inflammatory drugs tailored to specific germs can help patients in the ICU with severe community-acquired pneumonia recover faster. You may be eligible if you've been in the ICU less than 48 hours and meet certain diagnostic criteria.

NCT03856229Enrolling by invitation
Short steroid treatment for lung infection from PCP in HIV

This study tests whether short-term steroid treatment helps adults with a specific lung infection (PCP) that happens with HIV/AIDS. It compares outcomes in people who start steroids soon after admission while also taking standard PCP antibiotics.

México, State of Mexico
NCT07152600Not yet recruiting· Phase 3
Steroids for severe adenovirus pneumonia in adults

This trial tests whether adding steroids (corticosteroids) to standard care helps adults with severe adenovirus pneumonia recover faster. It is for people in the ICU who have a confirmed adenovirus infection and severe pneumonia.

NCT07352865Not yet recruiting· Phase 3
Corticosteroids for Severe Psittacosis Pneumonia in Adults

This trial tests whether adding corticosteroids (steroid medications) to standard care helps adults with severe pneumonia caused by Chlamydia psittaci (a bacteria from birds) who are in the intensive care unit. It aims to improve recovery and reduce the need for breathing machines or blood pressure support.

Hear when a new Pneumocystis Jiroveci Pneumonia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.